Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone during ovulation induction for in-vitro fertilization: a pilot study

M S Rein1, K V Jackson, D B Sable

  • 1Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA 02115, USA.

Human Reproduction (Oxford, England)
|February 1, 1996
PubMed
Summary

Dexamethasone (DEX) did not improve in-vitro fertilization (IVF) outcomes in women with elevated dehydroepiandrosterone sulphate (DHEAS). Adrenal androgen suppression with DEX showed no benefit for ovarian response or pregnancy rates in IVF cycles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uterine length and fertility outcomes: a cohort study in the IVF population.

Human reproduction (Oxford, England)·2013
Same author

Twin pregnancies with a 'vanished' embryo: a higher risk multiple gestation group?

Human reproduction (Oxford, England)·2011
Same author

Pregnancy outcomes in in vitro fertilization cycles with serum estradiol drop prior to human chorionic gonadotropin.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2005
Same author

Ethnic background and in vitro fertilization outcomes.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2005
Same author

Testing switchability of a new microemulsion formulation of cyclosporine.

Transplantation proceedings·2003
Same author

Bioremediation of textile azo dyes by an aerobic bacterial consortium using a rotating biological contactor.

Biotechnology progress·2003

Area of Science:

  • Reproductive Endocrinology
  • In-Vitro Fertilization (IVF)

Background:

  • Elevated dehydroepiandrosterone sulphate (DHEAS) may impact fertility.
  • Dexamethasone (DEX) is used to suppress adrenal androgens.

Purpose of the Study:

  • To investigate if DEX administration during ovulation induction improves IVF cycle outcomes in women with hyperandrogenism.

Main Methods:

  • Randomized controlled trial involving 25 patients with DHEAS > 2.5 µg/mL.
  • Patients received either DEX or placebo during ovulation induction with leuprolide acetate and human menopausal gonadotrophins (HMG).
  • 31 cycles were analyzed, including crossover patients.

Main Results:

  • A trend towards a higher implantation rate was observed in the placebo group (24%) compared to the DEX group (10%), though not statistically significant (P = 0.07).

Related Experiment Videos

  • No significant differences were found in other IVF outcome variables, including ovarian responsiveness, oocyte retrieval, fertilization rates, and clinical pregnancy rates.

    • Conclusions:

    • DEX-induced suppression of adrenal androgens does not appear to offer benefits for ovarian response or pregnancy outcomes in women undergoing IVF with elevated DHEAS.
    • Further research may be needed to explore alternative strategies for managing hyperandrogenism in IVF.